MatsukiyoCocokara & Co.
MatsukiyoCocokara & Co.
Your view on MSMKF
Overview
What the company does, where it operates, and who runs it.
About MatsukiyoCocokara & Co.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Kiyoo Matsumoto
- Headquarters
- 9-1 Shinmatsudo-Higashi, Matsudo, JP
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Kiyoo Matsumoto
- Headquarters
- 9-1 Shinmatsudo-Higashi, Matsudo, JP
MatsukiyoCocokara & Co. operates a chain of drug stores and pharmacies in Japan. As of June 30, 2020, it operated through a network of 1,726 stores in 47 prefectures in Japan. MatsukiyoCocokara & Co. was founded in 1932 and is based in Matsudo, Japan.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
Fair value for MatsukiyoCocokara & Co. from FRC's valuation model, read against the market price. MSMKF last traded at $18.17, 18.5× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for MatsukiyoCocokara & Co.. Starting points for MatsukiyoCocokara & Co.: P/E 18.5, EPS $145.90, beta -0.21 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for MatsukiyoCocokara & Co.. MatsukiyoCocokara & Co. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for MatsukiyoCocokara & Co.. Trailing twelve-month EPS for MatsukiyoCocokara & Co. stands at $145.90. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Analyst Ratings
- Strong Buy0
- Buy1
- Hold0
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrSep 2026 | Next QtrDec 2026 | Current YearFY Mar 2027 | Next YearFY Mar 2028 |
|---|---|---|---|---|
| Avg. estimate | JPY 34.27 | JPY 44.46 | JPY 152.93 | JPY 162.85 |
| Low estimate | JPY 34.06 | JPY 44.19 | JPY 150.85 | JPY 160.62 |
| High estimate | JPY 34.42 | JPY 44.65 | JPY 155.26 | JPY 165.32 |
| No. of analysts | 1 | 1 | 1 | 1 |
| Year-ago EPS | JPY 35.00 | JPY 40.78 | JPY 140.61 | — |
| Growth | -2.1% | +9.0% | +8.8% | — |
Revenue Estimate
| Revenue | Current QtrSep 2026 | Next QtrDec 2026 | Current YearFY Mar 2027 | Next YearFY Mar 2028 |
|---|---|---|---|---|
| Avg. estimate | JPY 292.46B | JPY 300.75B | JPY 1.16T | JPY 1.20T |
| Low estimate | JPY 288.56B | JPY 299.36B | JPY 1.15T | JPY 1.19T |
| High estimate | JPY 293.94B | JPY 301.75B | JPY 1.17T | JPY 1.22T |
| No. of analysts | 5 | 5 | 8 | 9 |
| Year-ago revenue | JPY 279.39B | JPY 290.50B | JPY 1.12T | — |
| Growth | +4.7% | +3.5% | +3.6% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 12, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for MatsukiyoCocokara & Co.. MatsukiyoCocokara & Co. has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
MatsukiyoCocokara & Co. valued side by side against its closest peers. MatsukiyoCocokara & Co. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
News
Latest headlines and market coverage.
Latest headlines and company announcements for MatsukiyoCocokara & Co.. Coverage tracks MatsukiyoCocokara & Co. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of MatsukiyoCocokara & Co.